Tenax Therapeutics, Inc.

Historical 13F Holders

Symbol
TENX
CUSIP
88032L605
All holders as of
Q1 2025
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 8 72.8 k $425 k
2025 Q1 24 2.01 M $13.1 M
2024 Q4 22 1.36 M $8.43 M
2024 Q3 20 1.23 M $4.25 M
2024 Q2 13 19.1 k $58.0 k
2024 Q1 12 7.76 k $32.7 k